Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
2.030
-0.050 (-2.40%)
Streaming Delayed Price
Updated: 9:35 AM EST, Mar 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
A Preview Of Macrogenics's Earnings
↗
November 03, 2023
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
October 31, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...
Via
PressReach
Why Shares of MacroGenics Are Jumping Thursday
↗
August 10, 2023
The company announced second-quarter earnings.
Via
The Motley Fool
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
September 05, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
August 31, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
3 Under-the-Radar Biotech Stocks to Buy in 2023
↗
August 19, 2023
All three biotech companies focus on oncology therapies.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
August 10, 2023
Via
Benzinga
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
↗
May 10, 2023
MGNX earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Recap: Macrogenics Q1 Earnings
↗
May 09, 2023
Via
Benzinga
Earnings Outlook For Macrogenics
↗
May 08, 2023
Via
Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
August 10, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Via
Benzinga
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
↗
August 10, 2023
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.
Via
Benzinga
Topics
ETFs
Economy
What 4 Analyst Ratings Have To Say About Macrogenics
↗
March 21, 2023
Via
Benzinga
Why MacroGenics Stock Tumbled Today
↗
March 17, 2023
The company had quite a comedown shortly after releasing its latest set of annual results.
Via
The Motley Fool
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
↗
August 10, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript
↗
August 09, 2023
MGNX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Topics
Earnings
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
July 31, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 05, 2023
Via
Benzinga
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
May 04, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
April 24, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
April 03, 2023
Via
Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
↗
March 23, 2023
Via
Benzinga
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
March 22, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
Why MacroGenics Stock Inched Higher on Monday
↗
March 20, 2023
A pair of more-bullish analyst evaluations gave hope to investors.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
↗
March 17, 2023
Via
Benzinga
Why Shares of MacroGenics Climbed Thursday
↗
March 16, 2023
The cancer-focused biotech delivered a strong earnings report.
Via
The Motley Fool
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
